Literature DB >> 33850112

Distinct uptake, amplification, and release of SARS-CoV-2 by M1 and M2 alveolar macrophages.

Jiadi Lv1, Zhenfeng Wang1, Yajin Qu2, Hua Zhu2, Qiangqiang Zhu1, Wei Tong2, Linlin Bao2, Qi Lv2, Ji Cong2, Dan Li2, Wei Deng2, Pin Yu2, Jiangping Song3, Wei-Min Tong4, Jiangning Liu5, Yuying Liu6,7, Chuan Qin8, Bo Huang9,10,11.   

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) invades the alveoli, where abundant alveolar macrophages (AMs) reside. How AMs respond to SARS-CoV-2 invasion remains elusive. Here, we show that classically activated M1 AMs facilitate viral spread; however, alternatively activated M2 AMs limit the spread. M1 AMs utilize cellular softness to efficiently take up SARS-CoV-2. Subsequently, the invaded viruses take over the endo-lysosomal system to escape. M1 AMs have a lower endosomal pH, favoring membrane fusion and allowing the entry of viral RNA from the endosomes into the cytoplasm, where the virus achieves replication and is packaged to be released. In contrast, M2 AMs have a higher endosomal pH but a lower lysosomal pH, thus delivering the virus to lysosomes for degradation. In hACE2 transgenic mouse model, M1 AMs are found to facilitate SARS-CoV-2 infection of the lungs. These findings provide insights into the complex roles of AMs during SARS-CoV-2 infection, along with potential therapeutic targets.

Entities:  

Year:  2021        PMID: 33850112     DOI: 10.1038/s41421-021-00258-1

Source DB:  PubMed          Journal:  Cell Discov        ISSN: 2056-5968            Impact factor:   10.849


  43 in total

1.  Phagocytosis, chemiluminescence, and cell volume of alveolar macrophages from neonatal and adult pigs.

Authors:  R B Zeidler; H D Kim
Journal:  J Leukoc Biol       Date:  1985-01       Impact factor: 4.962

2.  The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor Microenvironment.

Authors:  W Hans Meisen; Eric S Wohleb; Alena Cristina Jaime-Ramirez; Chelsea Bolyard; Ji Young Yoo; Luke Russell; Jayson Hardcastle; Samuel Dubin; Kamaldeen Muili; Jianhua Yu; Michael Caligiuri; Jonathan Godbout; Balveen Kaur
Journal:  Clin Cancer Res       Date:  2015-03-31       Impact factor: 12.531

3.  Flavored e-cigarette liquids and cinnamaldehyde impair respiratory innate immune cell function.

Authors:  Phillip W Clapp; Erica A Pawlak; Justin T Lackey; James E Keating; Steven L Reeber; Gary L Glish; Ilona Jaspers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-05-11       Impact factor: 5.464

4.  In vitro production of rabbit macrophage tumor cell cytotoxin.

Authors:  H Fisch; G E Gifford
Journal:  Int J Cancer       Date:  1983-07-15       Impact factor: 7.396

5.  COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis.

Authors:  Robert Lorenz Chua; Soeren Lukassen; Saskia Trump; Bianca P Hennig; Daniel Wendisch; Fabian Pott; Olivia Debnath; Loreen Thürmann; Florian Kurth; Maria Theresa Völker; Julia Kazmierski; Bernd Timmermann; Sven Twardziok; Stefan Schneider; Felix Machleidt; Holger Müller-Redetzky; Melanie Maier; Alexander Krannich; Sein Schmidt; Felix Balzer; Johannes Liebig; Jennifer Loske; Norbert Suttorp; Jürgen Eils; Naveed Ishaque; Uwe Gerd Liebert; Christof von Kalle; Andreas Hocke; Martin Witzenrath; Christine Goffinet; Christian Drosten; Sven Laudi; Irina Lehmann; Christian Conrad; Leif-Erik Sander; Roland Eils
Journal:  Nat Biotechnol       Date:  2020-06-26       Impact factor: 54.908

Review 6.  Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.

Authors:  W Joost Wiersinga; Andrew Rhodes; Allen C Cheng; Sharon J Peacock; Hallie C Prescott
Journal:  JAMA       Date:  2020-08-25       Impact factor: 56.272

7.  Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype.

Authors:  Degao Chen; Jing Xie; Roland Fiskesund; Wenqian Dong; Xiaoyu Liang; Jiadi Lv; Xun Jin; Jinyan Liu; Siqi Mo; Tianzhen Zhang; Feiran Cheng; Yabo Zhou; Huafeng Zhang; Ke Tang; Jingwei Ma; Yuying Liu; Bo Huang
Journal:  Nat Commun       Date:  2018-02-28       Impact factor: 14.919

8.  A Thermostable mRNA Vaccine against COVID-19.

Authors:  Na-Na Zhang; Xiao-Feng Li; Yong-Qiang Deng; Hui Zhao; Yi-Jiao Huang; Guan Yang; Wei-Jin Huang; Peng Gao; Chao Zhou; Rong-Rong Zhang; Yan Guo; Shi-Hui Sun; Hang Fan; Shu-Long Zu; Qi Chen; Qi He; Tian-Shu Cao; Xing-Yao Huang; Hong-Ying Qiu; Jian-Hui Nie; Yuhang Jiang; Hua-Yuan Yan; Qing Ye; Xia Zhong; Xia-Lin Xue; Zhen-Yu Zha; Dongsheng Zhou; Xiao Yang; You-Chun Wang; Bo Ying; Cheng-Feng Qin
Journal:  Cell       Date:  2020-07-23       Impact factor: 41.582

9.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.

Authors:  Markus Hoffmann; Hannah Kleine-Weber; Simon Schroeder; Nadine Krüger; Tanja Herrler; Sandra Erichsen; Tobias S Schiergens; Georg Herrler; Nai-Huei Wu; Andreas Nitsche; Marcel A Müller; Christian Drosten; Stefan Pöhlmann
Journal:  Cell       Date:  2020-03-05       Impact factor: 41.582

Review 10.  Part I. SARS-CoV-2 triggered 'PANIC' attack in severe COVID-19.

Authors:  Elliot M Frohman; Nicole R Villemarette-Pittman; Esther Melamed; Roberto Alejandro Cruz; Reid Longmuir; Thomas C Varkey; Lawrence Steinman; Scott S Zamvil; Teresa C Frohman
Journal:  J Neurol Sci       Date:  2020-05-21       Impact factor: 3.181

View more
  24 in total

1.  Time-Dependent Increase in Susceptibility and Severity of Secondary Bacterial Infections During SARS-CoV-2.

Authors:  Amanda P Smith; Evan P Williams; Taylor R Plunkett; Muneeswaran Selvaraj; Lindey C Lane; Lillian Zalduondo; Yi Xue; Peter Vogel; Rudragouda Channappanavar; Colleen B Jonsson; Amber M Smith
Journal:  Front Immunol       Date:  2022-05-12       Impact factor: 8.786

Review 2.  Protons to Patients: targeting endosomal Na+ /H+ exchangers against COVID-19 and other viral diseases.

Authors:  Hari Prasad
Journal:  FEBS J       Date:  2021-09       Impact factor: 5.622

3.  Role of Human Antigen R (HuR) in the Regulation of Pulmonary ACE2 Expression.

Authors:  Noof Aloufi; Zahraa Haidar; Jun Ding; Parameswaran Nair; Andrea Benedetti; David H Eidelman; Imed-Eddine Gallouzi; Sergio Di Marco; Sabah N Hussain; Carolyn J Baglole
Journal:  Cells       Date:  2021-12-22       Impact factor: 6.600

4.  Escaping alveolar macrophage endosomal retention explains massive expansion of SARS-CoV-2 delta variant.

Authors:  Zhenfeng Wang; Yabo Zhou; Linlin Bao; Dan Li; Jiadi Lv; Dianheng Wang; Shunshun Li; Wei-Min Tong; Jiangning Liu; Chuan Qin; Bo Huang
Journal:  Signal Transduct Target Ther       Date:  2021-12-17

5.  Clinical importance of serum heme oxygenase-1 measurement in patients with acute exacerbation of idiopathic pulmonary fibrosis triggered by coronavirus disease 2019.

Authors:  Yu Hara; Yume Oshima; Yoichi Tagami; Ayako Aoki; Hiroaki Fujii; Ami Izawa; Kenichi Seki; Akinori Kanai; Aya Yabe; Keisuke Watanabe; Nobuyuki Horita; Nobuaki Kobayashi; Takeshi Kaneko
Journal:  Respir Med Case Rep       Date:  2022-02-20

Review 6.  Cytokine Storm in COVID-19: Immunopathogenesis and Therapy.

Authors:  Christian Zanza; Tatsiana Romenskaya; Alice Chiara Manetti; Francesco Franceschi; Raffaele La Russa; Giuseppe Bertozzi; Aniello Maiese; Gabriele Savioli; Gianpietro Volonnino; Yaroslava Longhitano
Journal:  Medicina (Kaunas)       Date:  2022-01-18       Impact factor: 2.430

7.  An engineered nano-liposome-human ACE2 decoy neutralizes SARS-CoV-2 Spike protein-induced inflammation in both murine and human macrophages.

Authors:  Sandro Satta; Zhaojie Meng; Rebecca Hernandez; Susana Cavallero; Tong Zhou; Tzung K Hsiai; Changcheng Zhou
Journal:  Theranostics       Date:  2022-03-06       Impact factor: 11.600

8.  Time-Dependent Increase in Susceptibility and Severity of Secondary Bacterial Infection during SARS-CoV-2 Infection.

Authors:  Amanda P Smith; Evan P Williams; Taylor R Plunkett; Muneeswaran Selvaraj; Lindey C Lane; Lillian Zalduondo; Yi Xue; Peter Vogel; Rudragouda Channappanavar; Colleen B Jonsson; Amber M Smith
Journal:  bioRxiv       Date:  2022-03-01

9.  Airway administration of bisphosphate and dexamethasone inhibits SARS-CoV-2 variant infection by targeting alveolar macrophages.

Authors:  Zhenfeng Wang; Yabo Zhou; Linlin Bao; Dan Li; Jiadi Lv; Dianheng Wang; Shunshun Li; Jiangning Liu; Chuan Qin; Wei-Min Tong; Bo Huang
Journal:  Signal Transduct Target Ther       Date:  2022-04-06

Review 10.  Inflammasome activation at the crux of severe COVID-19.

Authors:  Setu M Vora; Judy Lieberman; Hao Wu
Journal:  Nat Rev Immunol       Date:  2021-08-09       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.